Dr Reddys launches generic version of Tobi in US market Farhat Nasim26 Jun 2019 9:37 AMThe product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene Medical Dialogues Bureau26 Jun 2019 3:30 AMBristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
More than 10 percent of Drug samples from Government sources Not of Standard Quality Meghna A Singhania25 Jun 2019 10:13 AMNew Delhi: Estimated 10.02% medicines of the sample of medicines from government sources tested by the government were found to be Not of Standard...
Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules Farhat Nasim25 Jun 2019 6:24 AMThe approved product, Oseltamivir Phosphate capsule is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La...
Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana Farhat Nasim25 Jun 2019 6:06 AMWith this investment of Rs 75 crores in the upcoming filling facility, Indian Immunologicals Limited expects to increase its capacity to supply...
Dr Reddys unveils generic version of Vitamin K1 injection in US Medical Dialogues Bureau25 Jun 2019 5:22 AMThe Vitamin K1 (Phytonadione) for Injectable Emulsion USP, 10 mg/ml brand and generic, had combined US sales of approximately USD 46.6 million MAT for...
Alembic Pharma gets USFDA nod for Bromfenac Ophthalmic Solution Farhat Nasim24 Jun 2019 6:55 AMThe approved product, Bromfenac Ophthalmic Solution is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution,...
Dr Reddys gets two USFDA observations for Vizag plants Farhat Nasim24 Jun 2019 5:39 AMHyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
GSK Pharma to optimise product portfolio to drive growth in India Medical Dialogues Bureau24 Jun 2019 3:49 AMGSK is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel...
Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA Meghna A Singhania23 Jun 2019 11:27 AMNew Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
GSK offers concessions to address Pfizer deal concerns Farhat Nasim23 Jun 2019 3:29 AMGSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
Price of 1000 plus essential medicines capped by Government: Ministers inform Parliament Farhat Nasim22 Jun 2019 9:43 AMThe parliament was also apprised about the details of drugs under the list of Essential Medicines, as included in the National List of Essential...
